- About CTTC
- Invention Disclosure
- News & Events
Live Attenuated Coronavirus Vaccines
The present invention is directed live, attenuated coronavirus vaccines. The vaccine comprises a viral genome encoding a p59 protein having at mutation at a specific tyrosine residue, and may include other attenuating mutations. Such viruses show reduced growth and pathogenicity in vivo.